In addition, some cytokines in the tumor microenvironment such as interleukin-2 (IL-2), interferon-α (interferon-α, IFNα) and interferon-γ (interferon-γ, IFNγ) have also been used in immunotherapy approaches (25). This evidence concerns the gene IFNG and neoplasm.